Login / Signup

An update on the latest strategies in retinal drug delivery.

Ketan RanchDisha ChawnaniHarshilkumar JaniDevarshi AcharyaChirag Amrutlal PatelShery JacobR Jayachandra BabuAmit K TiwariMoawia M Al-TabakhaSai H S Boddu
Published in: Expert opinion on drug delivery (2024)
Ideally, drug delivery system for treating retinal diseases should be less invasive in nature and exhibit sustained release up to several months. Though topical administration in the form of eye drops offers better patient compliance, its clinical utility is limited by nature of the drug. There is a wide range of delivery platforms available, however, it is not easy to modify any single platform to accommodate all types of drugs. Coordinated efforts between ophthalmologists and drug delivery scientists are necessary while developing therapeutic compounds, right from their inception.
Keyphrases
  • drug delivery
  • optical coherence tomography
  • diabetic retinopathy
  • cancer therapy
  • optic nerve
  • drug release
  • case report
  • high throughput
  • drug induced
  • wound healing
  • single cell
  • adverse drug
  • electronic health record